BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,679,917 | -19.3% | 71,010 | -2.6% | 0.03% | -13.2% |
| Q2 2023 | $3,321,415 | +13.2% | 72,902 | +0.7% | 0.04% | +8.6% |
| Q1 2023 | $2,934,962 | -20.2% | 72,361 | +0.3% | 0.04% | -23.9% |
| Q4 2022 | $3,678,454 | -2.2% | 72,169 | +3.3% | 0.05% | -9.8% |
| Q3 2022 | $3,763,000 | -14.8% | 69,872 | +1.6% | 0.05% | -10.5% |
| Q2 2022 | $4,418,000 | -14.9% | 68,791 | +2.8% | 0.06% | +3.6% |
| Q1 2022 | $5,191,000 | -8.7% | 66,942 | +1.1% | 0.06% | -5.2% |
| Q4 2021 | $5,686,000 | +7.6% | 66,238 | +0.8% | 0.06% | +11.5% |
| Q3 2021 | $5,284,000 | -0.1% | 65,700 | -0.0% | 0.05% | 0.0% |
| Q2 2021 | $5,290,000 | -4.2% | 65,719 | +0.3% | 0.05% | -10.3% |
| Q1 2021 | $5,524,000 | +7.0% | 65,492 | +1.8% | 0.06% | -1.7% |
| Q4 2020 | $5,162,000 | -2.6% | 64,333 | -2.4% | 0.06% | -16.9% |
| Q3 2020 | $5,301,000 | -10.9% | 65,918 | -4.6% | 0.07% | -15.5% |
| Q2 2020 | $5,948,000 | +5.2% | 69,087 | -0.8% | 0.08% | -11.6% |
| Q1 2020 | $5,652,000 | -2.2% | 69,614 | +0.7% | 0.10% | +28.4% |
| Q4 2019 | $5,779,000 | -3.7% | 69,109 | +0.8% | 0.07% | -10.8% |
| Q3 2019 | $5,998,000 | +15.5% | 68,574 | +8.2% | 0.08% | +13.7% |
| Q2 2019 | $5,192,000 | +0.2% | 63,390 | -0.6% | 0.07% | -2.7% |
| Q1 2019 | $5,183,000 | +21.1% | 63,749 | -2.0% | 0.08% | +5.6% |
| Q4 2018 | $4,280,000 | -13.5% | 65,033 | +1.3% | 0.07% | +1.4% |
| Q3 2018 | $4,948,000 | +5.5% | 64,179 | +1.0% | 0.07% | 0.0% |
| Q2 2018 | $4,691,000 | +13.4% | 63,528 | -0.1% | 0.07% | +9.4% |
| Q1 2018 | $4,135,000 | +4.1% | 63,579 | +3.4% | 0.06% | +4.9% |
| Q4 2017 | $3,973,000 | +4.0% | 61,467 | +1.0% | 0.06% | -3.2% |
| Q3 2017 | $3,820,000 | +5.9% | 60,875 | +2.2% | 0.06% | +1.6% |
| Q2 2017 | $3,607,000 | +21.2% | 59,577 | +3.9% | 0.06% | +17.0% |
| Q1 2017 | $2,975,000 | -28.7% | 57,362 | -39.1% | 0.05% | -32.9% |
| Q4 2016 | $4,173,000 | +3.5% | 94,114 | +11.1% | 0.08% | -2.5% |
| Q3 2016 | $4,033,000 | +39.1% | 84,725 | +32.1% | 0.08% | +30.6% |
| Q2 2016 | $2,900,000 | +16.2% | 64,129 | +5.6% | 0.06% | +12.7% |
| Q1 2016 | $2,495,000 | +7.0% | 60,742 | -0.6% | 0.06% | +5.8% |
| Q4 2015 | $2,332,000 | +17.4% | 61,116 | +1.0% | 0.05% | +10.6% |
| Q3 2015 | $1,987,000 | -52.4% | 60,491 | +1.4% | 0.05% | -48.4% |
| Q2 2015 | $4,171,000 | +1.2% | 59,649 | -0.8% | 0.09% | +1.1% |
| Q1 2015 | $4,120,000 | -3.9% | 60,152 | +2.8% | 0.09% | -6.2% |
| Q4 2014 | $4,289,000 | +2.1% | 58,519 | +0.0% | 0.10% | -4.0% |
| Q3 2014 | $4,199,000 | +1.5% | 58,512 | +2.3% | 0.10% | +3.1% |
| Q2 2014 | $4,136,000 | -3.9% | 57,211 | -2.2% | 0.10% | -6.7% |
| Q1 2014 | $4,306,000 | +7.6% | 58,521 | +1.7% | 0.10% | +6.1% |
| Q4 2013 | $4,002,000 | +5.6% | 57,538 | -0.2% | 0.10% | -4.9% |
| Q3 2013 | $3,788,000 | +0.1% | 57,665 | +5.6% | 0.10% | -8.0% |
| Q2 2013 | $3,783,000 | – | 54,611 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |